Literature DB >> 1349675

Mortality from tobacco in developed countries: indirect estimation from national vital statistics.

R Peto1, A D Lopez, J Boreham, M Thun, C Heath.   

Abstract

Prolonged cigarette smoking causes even more deaths from other diseases than from lung cancer. In developed countries, the absolute age-sex-specific lung cancer rates can be used to indicate the approximate proportions due to tobacco of deaths not only from lung cancer itself but also, indirectly, from vascular disease and from various other categories of disease. Even in the absence of direct information on smoking histories, therefore, national mortality from tobacco can be estimated approximately just from the disease mortality statistics that are available from all major developed countries for about 1985 (and for 1975 and so, by extrapolation, for 1995). The relation between the absolute excess of lung cancer and the proportional excess of other diseases can only be approximate, and so as not to overestimate the effects of tobacco it has been taken to be only half that suggested by a recent large prospective study of smoking and death among one million Americans. Application of such methods indicates that, in developed countries alone, annual deaths from smoking number about 0.9 million in 1965, 1.3 million in 1975, 1.7 million in 1985, and 2.1 million in 1995 (and hence about 21 million in the decade 1990-99: 5-6 million European Community, 5-6 million USA, 5 million former USSR, 3 million Eastern and other Europe, and 2 million elsewhere, [ie, Australia, Canada, Japan, and New Zealand]). More than half these deaths will be at 35-69 years of age: during the 1990s tobacco will in developed countries cause about 30% of all deaths at 35-69 (making it the largest single cause of premature death) plus about 14% of all at older ages. Those killed at older ages are on average already almost 80 years old, however, and might have died soon anyway, but those killed by tobacco at 35-69 lose an average of about 23 years of life. At present just under 20% of all deaths in developed countries are attributed to tobacco, but this percentage is still rising, suggesting that on current smoking patterns just over 20% of those now living in developed countries will eventually be killed by tobacco (ie, about a quarter of a billion, out of a current total population of just under one and a quarter billion).

Entities:  

Mesh:

Year:  1992        PMID: 1349675     DOI: 10.1016/0140-6736(92)91600-d

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  293 in total

Review 1.  Impact of passive smoking.

Authors:  U K Singh; S Suman; V K Singh; R K Sinha
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

2.  Smoking cessation at the workplace. Results of a randomised controlled intervention study. Worksite physicians from the AIREL group.

Authors:  T Lang; V Nicaud; K Slama; A Hirsch; E Imbernon; M Goldberg; L Calvel; P Desobry; J P Favre-Trosson; C Lhopital; P Mathevon; D Miara; A Miliani; F Panthier; G Pons; C Roitg; M Thoores
Journal:  J Epidemiol Community Health       Date:  2000-05       Impact factor: 3.710

3.  Associations of family environment and individual factors with tobacco, alcohol, and illicit drug use in adolescents.

Authors:  B Challier; N Chau; R Prédine; M Choquet; B Legras
Journal:  Eur J Epidemiol       Date:  2000-01       Impact factor: 8.082

4.  Simulated effect of tobacco tax variation on population health in California.

Authors:  R M Kaplan; C F Ake; S L Emery; A M Navarro
Journal:  Am J Public Health       Date:  2001-02       Impact factor: 9.308

5.  Bibliometric analysis of Spanish scientific publications on tobacco use during the period 1970-1996.

Authors:  J A García-López
Journal:  Eur J Epidemiol       Date:  1999-01       Impact factor: 8.082

6.  Increased mortality among Danish women: population based register study.

Authors:  K Juel
Journal:  BMJ       Date:  2000-08-05

7.  Characterization of the smoking habit among high school students in Syria.

Authors:  W Maziak; F Mzayek
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

Review 8.  Vaccines against nicotine: how effective are they likely to be in preventing smoking?

Authors:  F J Vocci; C N Chiang
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

9.  Risk behaviours and self rated health in Russia 1998.

Authors:  P Carlson
Journal:  J Epidemiol Community Health       Date:  2001-11       Impact factor: 3.710

10.  Cigarette use among male and female grade 8-10 students of different ethnicity in South African schools.

Authors:  D Swart; P Reddy; R A C Ruiter; H de Vries
Journal:  Tob Control       Date:  2003-03       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.